drugset / Trial / NCT00241007

A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension

NCT00241007

Phase 3 Completed 836 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

SAFETY EXTENSION STUDY TO THE CORE STUDY CVAH631C2301

Timeline

Start
2003-12
Primary completion
2005-03
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown
Subject Valsartan Small molecule

Indications